SEARCH

SEARCH BY CITATION

References

  • Al-Faleh FZ, Al-Jeffri M, Ramia S et al. (1999) Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. Journal of Infection 38, 167170.
  • Banatvala J, Van Damme P & Oehen S (2000) Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 19, 877885.
  • Carman WF, Zanetti AR, Karayiannis P et al. (1990) Vaccine-induced escape mutant of hepatitis B virus. Lancet 336, 325329.
  • Chang MH, Chen CJ, Lai MS et al. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. New England Journal of Medicine 336, 18551859.
  • Da Villa G (2000) Rationale for the infant and adolescent vaccination programmes in Italy. Vaccine 18, S31S34.
  • FitzSimons D, FranÇois G, Hall A et al. (2005) Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 23, 41584166.
  • Fortuin M, Karthigesu V, Allison L et al. (1994) Breakthrough infections and identification of a novel variant in Gambian children immunized with hepatitis B vaccine. Journal of Infectious Diseases 169, 13741376.
  • Gust ID (1996) Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 38 (Suppl. 2), S18S23.
  • Harpaz R, McMahon BJ, Margolis HS, Shapiro CN, Havron D, Carpenter G et al. (2000) Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. Journal of Infectious Diseases 181, 413418.
  • Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM & Chen DS (1997) Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 26, 786791.
  • Hsu HY, Chang MH, Ni YH & Chen HL (2004) Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53, 14991503.
  • Kane M (1995) Global programme for control of hepatitis B infection. Vaccine 13 (Suppl. 1), 4749.
  • Kao JH & Chen DS (2002) Recent updates in hepatitis vaccination and the prevention of hepatocellular carcinoma. International Journal of Cancer 97, 269271.
  • Liao SS, Li RC, Li H et al. (1999) Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine 17, 26612666.
  • McMahon BJ, Bruden D, Petersen KM et al. (2005) Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Annals of Internal Medicine 142, 333341.
  • Men K, Xu D & Yan Y (1996) The preliminary study on the hepatitis B virus infection rate of peripheral blood mononuclear cell in both HBsAg and HBeAg-positive pregnant women and its role in intrauterine transmission. Chung-Hua Fu Chan Ko Tsa Chih 31, 597599.
  • Poovorawan Y, Chongsrisawat V, Theamboonlers A, Vimolkej L & Yano M (1997) Is there evidence for intrauterine HBV infection in newborns of hepatitis B carrier mothers. Southeast Asian Journal of Tropical Medicine and Public Health 28, 365369.
  • Poovorawan Y, Theamboonlers A, Vimolket T et al. (2001) Impact of hepatitis B immunisation as part of the EPI. Vaccine 19, 943949.
  • Viviani S, Jack A, Hall AJ et al. (1999) Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine 17, 29462950.
  • Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C & McMahon BJ (1997) Protection provided by hepatitis B vaccine in a Yupik Eskimo population – results of a 10-year study. Journal of Infectious Diseases 175, 674677.
  • Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R & Hoare S (1991) Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet 337, 747750.
  • Wilson JN, Nokes DJ & Carman WF (1999) The predicted pattern of emergence of vaccine-resistant hepatitis B: a cause for concern? Vaccine 17, 973978.
  • Zhao S, Xu Z & Lu Y (2000) A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. International Journal of Epidemiology 29, 744752.